Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Biological test for menopausal osteoporosis]

B Klein1, N Rojansky

  • 1Dept. of Experimental Surgery, Hadassah-Hebrew University Medical Center, Ein Kerem, Jerusalem.

Harefuah
|April 1, 1997
PubMed
Summary

A new biological test identifies women at high risk for osteoporosis by measuring serum effects on bone cell mineralization. This test shows promise for early osteoporosis diagnosis in postmenopausal women.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Numerical simulation of vertical cavity surface emitting lasers.

Optics express·2009
Same author

[Colonic perforation after extracorporeal shock wave lithotripsy].

Deutsche medizinische Wochenschrift (1946)·2009
Same author

Thyroid surgery in Burkina Faso, West Africa: experience from a surgical help program.

World journal of surgery·2008
Same author

[Oocyte and embryo quality: do the apoptotic markers have a place in the preimplantation genetic diagnostic?].

Gynecologie, obstetrique & fertilite·2008
Same author

[Could apoptotic markers help the exploration of male infertility?].

Gynecologie, obstetrique & fertilite·2008
Same author

ETV6 mutations and loss in AML-M0.

Leukemia·2008

Area of Science:

  • Endocrinology
  • Cell Biology
  • Bone Metabolism

Context:

  • Osteoporosis is a significant public health concern, particularly in western countries, affecting approximately 25% of women over 65.
  • Loss of gonadal function is a primary risk factor for osteoporosis.
  • Current diagnostic methods identify established osteoporosis but fail to predict high-risk individuals.

Purpose:

  • To develop and validate a novel biological test for predicting osteoporosis risk in postmenopausal women.
  • To assess the influence of postmenopausal serum on osteoprogenitor cell proliferation, differentiation, and mineralization.

Summary:

  • A biological test was developed using rat osteoprogenitor cells cultured with serum from postmenopausal women.
  • The test measures the impact of serum on bone cell proliferation, differentiation, and mineralization.
  • Rapid bone losers exhibited a significantly lower mineralization index compared to non-osteopenic women (p < 0.0001).

Impact:

  • This preliminary study suggests that a serum-based biological test measuring bone cell mineralization could aid in early osteoporosis diagnosis.
  • The findings highlight the potential for a new diagnostic tool to identify women at high risk for osteoporosis, enabling timely intervention.

Related Experiment Videos